Institute for Onc/Rad Serbia
Belgrade 11000
0 studies enrolling now · 1 studies all time
What they study most
Breast Cancer
Studies at this site
A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy
— Stopped early